Wedbush Lowers Earnings Estimates for Huron Consulting Group

Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) - Research analysts at Wedbush lowered their Q2 2025 EPS estimates for Huron Consulting Group in a report released on Wednesday, April 30th. Wedbush analyst D. Ives now expects that the business services provider will post earnings per share of $1.77 for the quarter, down from their previous forecast of $1.79. Wedbush has a "Outperform" rating and a $165.00 price target on the stock. The consensus estimate for Huron Consulting Group's current full-year earnings is $6.10 per share. Wedbush also issued estimates for Huron Consulting Group's Q3 2025 earnings at $1.86 EPS, FY2025 earnings at $7.27 EPS, Q2 2026 earnings at $2.22 EPS, Q3 2026 earnings at $2.23 EPS and FY2026 earnings at $8.51 EPS.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last released its quarterly earnings data on Tuesday, April 29th. The business services provider reported $1.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.16 by $0.52. The business had revenue of $404.14 million during the quarter, compared to analysts' expectations of $389.27 million. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The company's revenue for the quarter was up 11.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.23 EPS.

A number of other equities analysts also recently issued reports on HURN. Benchmark reaffirmed a "buy" rating and issued a $165.00 price target on shares of Huron Consulting Group in a report on Wednesday, March 26th. Truist Financial upped their target price on shares of Huron Consulting Group from $165.00 to $180.00 and gave the company a "buy" rating in a report on Tuesday, March 4th. Barrington Research increased their target price on shares of Huron Consulting Group from $167.00 to $173.00 and gave the company an "outperform" rating in a research report on Monday. William Blair reissued an "outperform" rating on shares of Huron Consulting Group in a research report on Wednesday, March 26th. Finally, StockNews.com lowered Huron Consulting Group from a "buy" rating to a "hold" rating in a report on Friday, May 2nd. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Huron Consulting Group presently has an average rating of "Moderate Buy" and an average target price of $170.75.

Huron Consulting Group Stock Up 1.6 %

NASDAQ HURN traded up $2.32 during trading on Friday, reaching $151.59. 52,887 shares of the company's stock were exchanged, compared to its average volume of 148,167. Huron Consulting Group has a 1 year low of $84.87 and a 1 year high of $153.85. The stock has a market cap of $2.61 billion, a P/E ratio of 32.90 and a beta of 0.23. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.61 and a current ratio of 1.61. The company has a 50 day moving average price of $143.09 and a two-hundred day moving average price of $130.37.

Insider Activity at Huron Consulting Group

In other Huron Consulting Group news, Director John Mccartney sold 500 shares of the business's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $151.13, for a total value of $75,565.00. Following the transaction, the director now directly owns 55,688 shares of the company's stock, valued at approximately $8,416,127.44. The trade was a 0.89 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director H Eugene Lockhart sold 12,500 shares of the firm's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $150.00, for a total transaction of $1,875,000.00. Following the completion of the sale, the director now owns 12,172 shares of the company's stock, valued at $1,825,800. This trade represents a 50.66 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 76,239 shares of company stock worth $11,168,801 in the last quarter. Company insiders own 2.15% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Peapack Gladstone Financial Corp acquired a new position in Huron Consulting Group during the 3rd quarter worth approximately $220,000. Franklin Resources Inc. grew its holdings in Huron Consulting Group by 20.5% during the third quarter. Franklin Resources Inc. now owns 395,788 shares of the business services provider's stock worth $42,306,000 after acquiring an additional 67,239 shares during the period. Principal Financial Group Inc. raised its position in Huron Consulting Group by 4.7% in the third quarter. Principal Financial Group Inc. now owns 380,024 shares of the business services provider's stock worth $41,308,000 after acquiring an additional 17,146 shares in the last quarter. Nordea Investment Management AB lifted its holdings in Huron Consulting Group by 4.7% in the fourth quarter. Nordea Investment Management AB now owns 74,244 shares of the business services provider's stock valued at $9,321,000 after acquiring an additional 3,346 shares during the period. Finally, Diversified Trust Co boosted its position in shares of Huron Consulting Group by 9.1% during the 4th quarter. Diversified Trust Co now owns 5,907 shares of the business services provider's stock worth $734,000 after purchasing an additional 493 shares in the last quarter. 93.90% of the stock is currently owned by institutional investors and hedge funds.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.